<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: antiviral therapy</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Team develops mathematical model to measure hidden HIV</title>
   	 <description>(Medical Xpress)—Scientists have long believed that measuring the amount of HIV in a person's blood is an indicator of whether the virus is actively reproducing. A University of Delaware-led research team reports new evidence that hidden virus replication may be occurring within the body's tissue, despite undetectable virus levels in the blood.</description>
     <link>http://medicalxpress.com/news/2013-05-team-mathematical-hidden-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 08 May 2013 09:00:03 EST</pubDate>
	 <guid isPermaLink="false">news287220884</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/teamdevelops.jpg" width="90" height="90" />
</item>
<item>
     <title>New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection</title>
   	 <description>A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.</description>
     <link>http://medicalxpress.com/news/2013-04-drug-immune-infected-cells-animal.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 26 Apr 2013 15:45:41 EST</pubDate>
	 <guid isPermaLink="false">news286209917</guid>
	 
</item>
<item>
     <title>Improved molecular tools streamline influenza testing and management</title>
   	 <description>Over 40,000 people die each year in the United States from influenza-related diseases. In patients whose immune systems are compromised, antiviral therapy may be life-saving, but it needs to be initiated quickly. It is therefore crucial to diagnose and type the influenza rapidly. Scientists in the Netherlands have designed and evaluated a set of molecular assays that they say are a sensitive and good alternative for conventional diagnostic methods and can produce results in one day without the need for additional equipment. The results are published in The Journal of Molecular Diagnostics.</description>
     <link>http://medicalxpress.com/news/2013-04-molecular-tools-influenza.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 17 Apr 2013 12:49:57 EST</pubDate>
	 <guid isPermaLink="false">news285421790</guid>
	 
</item>
<item>
     <title>Better long-term outcomes with low hep C viral load</title>
   	 <description>(HealthDay)—In patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), low HCV viral load predicts better long-term surgical outcomes, regardless of the serologic eradication of HCV, according to research published in the Feb. 20 issue of the Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2013-03-long-term-outcomes-hep-viral.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 25 Mar 2013 12:50:01 EST</pubDate>
	 <guid isPermaLink="false">news283430105</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/betterlongte.jpg" width="90" height="90" />
</item>
<item>
     <title>Nanoparticles loaded with bee venom kill HIV</title>
   	 <description>(Medical Xpress)—Nanoparticles carrying a toxin found in bee venom can destroy human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, researchers at Washington University School of Medicine in St. Louis have shown. The finding is an important step toward developing a vaginal gel that may prevent the spread of HIV, the virus that causes AIDS.</description>
     <link>http://medicalxpress.com/news/2013-03-nanoparticles-bee-venom-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Fri, 08 Mar 2013 08:20:29 EST</pubDate>
	 <guid isPermaLink="false">news281953153</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/4-nanoparticle.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers describe first 'functional HIV cure' in an infant</title>
   	 <description>A team of researchers from Johns Hopkins Children's Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School describe the first case of a so-called &quot;functional cure&quot; in an HIV-infected infant. The finding, the investigators say, may help pave the way to eliminating HIV infection in children.</description>
     <link>http://medicalxpress.com/news/2013-03-functional-hiv-infant.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Sun, 03 Mar 2013 16:39:40 EST</pubDate>
	 <guid isPermaLink="false">news281551169</guid>
	 
</item>
<item>
     <title>Sustained virological response linked with improved survival for patients with chronic HCV infection</title>
   	 <description>Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with a lower risk of all-cause mortality compared with patients without SVR, according to a study in the December 26 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2012-12-sustained-virological-response-linked-survival.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 25 Dec 2012 16:00:02 EST</pubDate>
	 <guid isPermaLink="false">news275576845</guid>
	 
</item>
<item>
     <title>Antiviral therapy may cut recurrence of hepatitis B-linked liver cancer</title>
   	 <description>(HealthDay)—People with liver cancer tied to infection with the hepatitis B virus who got antiviral therapy after cancer surgery had a lower risk of tumor recurrence than those who did not get it, according to a new study.</description>
     <link>http://medicalxpress.com/news/2012-11-antiviral-therapy-recurrence-hepatitis-b-linked.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 12 Nov 2012 17:30:01 EST</pubDate>
	 <guid isPermaLink="false">news271960674</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/antiviralthe.jpg" width="90" height="90" />
</item>
<item>
     <title>Guideline: Steroid pills effective for treating facial paralysis in Bell's palsy</title>
   	 <description>For people experiencing first-time symptoms of Bell's palsy, steroid pills very likely are the most effective known treatment for recovering full strength in the facial muscles, according to a guideline published in the November 7, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology. Bell's palsy is a nerve disorder that affects muscle movement in the face and usually leaves half of the face temporarily paralyzed.</description>
     <link>http://medicalxpress.com/news/2012-11-guideline-steroid-pills-effective-facial.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 07 Nov 2012 16:00:09 EST</pubDate>
	 <guid isPermaLink="false">news271517829</guid>
	 
</item>
<item>
     <title>Antiviral therapy may halve risk of liver cancer after chronic hepatitis C infection</title>
   	 <description>Treating chronic hepatitis C infection with antiviral drugs could halve the risk of developing the most common form of liver cancer, in some cases, indicates an analysis of the published research in one of the new BMJ Open Editions.</description>
     <link>http://medicalxpress.com/news/2012-10-antiviral-therapy-halve-liver-cancer.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 22 Oct 2012 18:30:04 EST</pubDate>
	 <guid isPermaLink="false">news270137112</guid>
	 
</item>
<item>
     <title>Hep B screening urged before TNF-alpha inhibitor therapy</title>
   	 <description>(HealthDay) -- All patients with psoriasis should be screened for hepatitis B surface antigen and hepatitis B core antibody prior to the initiation of tumor necrosis factor-alpha inhibitor therapy, according to research published online June 25 in the Journal of the American Academy of Dermatology.</description>
     <link>http://medicalxpress.com/news/2012-07-hep-screening-urged-tnf-alpha-inhibitor.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sun, 01 Jul 2012 13:51:13 EST</pubDate>
	 <guid isPermaLink="false">news260369467</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/hepbscreenin.jpg" width="90" height="90" />
</item>
<item>
     <title>Hepatitis B screening before chemo deemed cost-effective</title>
   	 <description>(HealthDay) -- Universal hepatitis B virus (HBV) screening before chemotherapy for lymphoma reduces costs in most settings, according to a study published online June 18 in the Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2012-06-hepatitis-screening-chemo-deemed-cost-effective.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 20 Jun 2012 17:10:01 EST</pubDate>
	 <guid isPermaLink="false">news259429983</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/hepatitisbsc.jpg" width="90" height="90" />
</item>
<item>
     <title>Study shows genital herpes can reactivate even during high dose antiviral therapy</title>
   	 <description>A study combining three trials of antiviral therapy to treat genital herpes (herpes simplex virus type 2/HSV-2) has shown that the virus can reactivate in 'breakthrough episodes' even when doses of antiviral therapy are high. Thus new therapies are needed to successfully prevent onward transmission of this common infection that affects some one in five of the general population. These are the conclusions of an Article published Online First by the Lancet, written by Dr Christine Johnston, University of Washington Virology Research Clinic, Seattle, WA, USA, and colleagues.</description>
     <link>http://medicalxpress.com/news/2012-01-genital-herpes-reactivate-high-dose.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 04 Jan 2012 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news244915701</guid>
	 
</item>
<item>
     <title>Researchers pilot new acute hepatitis C screening strategy for HIV-infected patients</title>
   	 <description>Researchers at The Miriam Hospital demonstrated a practical strategy for regularly screening HIV-infected patients for acute hepatitis C virus infection (HCV), a &quot;silent epidemic&quot; that is rising undetected in this population and can lead to serious health complications.</description>
     <link>http://medicalxpress.com/news/2011-10-acute-hepatitis-screening-strategy-hiv-infected.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 18 Oct 2011 12:00:01 EST</pubDate>
	 <guid isPermaLink="false">news238157205</guid>
	 
</item>
<item>
     <title>HIV drug could prevent cervical cancer</title>
   	 <description>A widely used HIV drug could be used to prevent cervical cancer caused by infection with the human papilloma virus (HPV), say scientists.</description>
     <link>http://medicalxpress.com/news/2011-05-hiv-drug-cervical-cancer.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 03 May 2011 11:10:15 EST</pubDate>
	 <guid isPermaLink="false">news223639796</guid>
	 
</item>


</channel>
</rss>
